Antibody Drug Regeneron Enters Clinical Trials At UM October 15, 2020 • Clark Kent 0 (Visited 1 times, 1 visits today) Related posts: AstraZeneca Phase 3 COVID Vaccine Clinical Trials Begin President’s COVID Treatment Includes Experimental Antibody Cocktail That UM Is Conducting Clinical Trials State to report antibody results as more test sites are added in South Florida AstraZeneca Restarts Clinical Trials Of Oxford Coronavirus Vaccine Contact Tracers Needed In Miami